Skip to main content

Table 2 Prior treatment of the ITT population (n = 26)

From: A phase 2, single-arm study of an autologous dendritic cell treatment against mucin 1 in patients with advanced epithelial ovarian cancer

  

Patients

Surgery

26

100%

 BSO

24

92%

 TAH

22

85%

 Omentectomy

25

96%

Chemotherapy

  

 Prior platinum regimen

26

100%

 1 prior line

9

35%

 2 prior lines

2

8%

 3 prior lines

7

27%

 4 prior lines

4

15%

 5 prior lines

4

15%

Best response to most recent chemotherapy

  

 CR/NE

6

23%

 PR

5

19%

 SD

3

12%

 PD

11

42%

 Not known

1

4%

Radiotherapy

4

15%

Hormone therapy

3

12%

Immunotherapy

2

8%

  1. BSO, bilateral salpingo-oophorectomy; CR, complete response; NE, not evaluable; PD, progressive disease; PR, partial response; SD, stable disease; TAH, total abdominal hysterectomy.
Back to article page